• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

First Phase Advertising Results Indicate Liberator at "Beginning of 'Important Growth' Phase," States CEO, Mark Libratore

Posted on: Monday, 17 September 2007, 12:00 CDT

STUART, Fla., Sept. 17 /PRNewswire-FirstCall/ -- Liberator Medical Holdings, Inc. (BULLETIN BOARD: LBMH.OB) today announced better-than-expected results from recent national advertising efforts. "We have increased our September advertising budget," stated Mark Libratore, Chief Executive Officer, "in response to the excellent results in August, and regard this success as the beginning of an important growth phase for Liberator. I credit my present management team's collaboration in achieving this milestone."

Mr. Libratore brings a unique ad-based competitive advantage toward achieving Liberator's goals of rapid expansion in several of the healthcare market's highest-opportunity growth segments. As creator of the advertising- driven marketing model that fueled the growth of his former company, Liberty Medical Supply, into a diabetes super-brand, he and his management team are excited, but not surprised, to see that model succeed again for Liberator.

"In fact," comments CFO Bob Davis, "based on the response rate of our current advertising, we expect to exceed the sales dollars to advertising dollars ratio that was initially achieved at Liberty Medical Supply, Inc. for their fiscal year 1998, when they nearly quadrupled sales over the prior year, which has not been achieved by Liberty since." -- Liberty, which was eventually acquired by PolyMedica, was a principal component in PolyMedica's $1.5 Billion acquisition by Medco in August of this year.

About Liberator Medical Holdings, Inc.

Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc. established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. As an Exemplary Provider Accredited by The Compliance Team, the Company's unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Approximately 75% of its revenue comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes, urological, ostomy and mastectomy patients. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

Safe Harbor Statement

Certain statements in this press release that are not historical, but are forward-looking, and are subject to known and unknown risks and uncertainties which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this press release. Such risks and uncertainties may include, but are not limited to, the Company's need to raise equity capital and its ability to obtain equity financing on acceptable terms, if at all, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services, commercial acceptance and viability of new services, pricing and competition, reliance upon subcontractors, the timing of new technology and product introductions, and the risk of early obsolescence. Further, Liberator Holdings is a development stage company that operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond the Company's control, such as announcements and product development by competing product and competing service providers.

Liberator Medical Holdings, Inc.

CONTACT: Mark Libratore, President and Chief Executive Officer,+1-772-287-2414, investors@liberatormedical.com

Web site: http://www.liberatormedical.com/

Source: PRNewswire-FirstCall

More News in this Category